key: cord-0684999-zy7optw4 authors: Cruz, Jonas Carneiro; Martins, Carolina Kakiuthi; Neto, Albert Katchborian title: Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil date: 2021-09-15 journal: Lancet Child Adolesc Health DOI: 10.1016/s2352-4642(21)00265-0 sha: 2962fb3fd3d6ff9e95d7cb6fc317397d73901ab2 doc_id: 684999 cord_uid: zy7optw4 nan ages (eg, pulmonary contusions), paediatric victims are more likely to also suffer head and burn injuries and to require operative intervention. 2 An injury metric incorporating mechanisms of injury such as blast injuries while also accounting for patient age could improve the triage and care of paediatric patients with trauma in conflict zones. We propose that the ideal paediatric injury severity scoring system would incorporate anatomic and physiological data, mechanism of injury, and patient age. Our recently developed Trauma Composite Score incorporates these elements, as well as mechanism of injury and patient age. 3 Although the Trauma Composite Score outperforms Injury Severity Score and Shock Index Pediatric-Adjusted as an injury severity scoring system, the Trauma Composite Score has not been compared with other paediatric-specific injury scoring systems such as International Classification of Diseases (ICD) Critical Care Severity Score, the ICD General Anesthesia Severity Score, or the Pediatric Trauma Score. 4 ,5 It will be important to also compare these scoring systems in various settings, including conflict zones, to establish the most effective tools for triaging paediatric patients with trauma. We declare no competing interests. We read with great interest the work by Eduardo Oliveira and colleagues, 1 who used a multivariate survival analysis to estimate the risk factors for COVID-19 mortality among children and adolescents admitted to hospital in Brazil. The study has important impli cations to guide policy and improve care of individuals at increased risk of death. Here, we highlight some methodological concerns and limitations. First, the clustering of different clin ical disorders in a variable containing the sum of the number of co morbidities might be considered a poor index. For example, a comprehensive study of adult patients admitted to hos pital with COVID-19 in Brazil 2 revealed that comorbidities such as obesity were significantly associated with poor prognosis, where as asthma was reported to be inversely correlated with mortality risk. In this context, the differences in mortality might be con founded by the comorbidities in each age group. For example, obesity is more frequent in adolescents than in younger children, 3 and chromosomal abnormality or syn dromes are more preva lent in infants than in older children. 4 Therefore, these findings indi cate that comorbidities should have been treated separately in the multi variate analysis. In addition, the authors ignored the variable of other co morbidities, available in the Influenza Epidemiological e40 www.thelancet.com/child-adolescent Vol 5 October 2021 Surveillance Information System (SIVEP-GRIPE) dataset. Second, the authors should have men tioned that the risk factors included in SIVEP-GRIPE were selfreported (provided by the patients them selves or their families). Therefore, the analysis could be biased by the patients' knowledge regarding their medical condition. Additionally, some variables could be incorrectly coded in the electronic records; for instance, we identified in the current SIVEP-GRIPE platform at least 14 puerperal individuals younger than 10 years, which was probably a data entry error (leading to outliers). Finally, the author did not mention any effort to test the regression model assumptions (eg, non-linearity relationship and residual analysis). The inclusion of the variables in the final multivariate model was based on a univariate parameter, which could have suppressed other important variables that should be included in the model. There was also no internal validation or crossvalidation. Therefore, we believe that our concerns should affect how the data presented by Oliveira and colleagues 1 should be interpreted. We declare no competing interests. We read the Article by Eduardo Oliveira and colleagues 1 with great interest and believe the findings from this cohort study are important, given that they directly investigated the risk factors associated with COVID-19 in children and adolescents. In their study, patients were roughly evenly distributed among the three age groups, and risk of death was increased in infants younger than age 2 years and in adolescents aged 12-19 years, relative to children aged 2-11 years. However, the authors did not provide a rationale for the age groupings. The lower age limit of adolescence is generally defined as 10 years, 2 including by the UN and WHO. 3 Additionally, a study of COVID-19 trends between March 1, 2020, and Dec 12, 2020, in young people aged 0-24 years in the USA found that more than 81% of patients were older than 10 years. 4 Therefore, we are interested to know how a different age stratification (<2 years, 2-9 years, and 10-19 years) would affect the study findings, and we believe that comparison between these age groups could provide further insight on the COVID-19 mortality risk in adolescents. It is important to present the median and mean ages in the three age groups, given that this information will help readers understand how mortality risk is influenced by age within the broad age bands. Having data related to symptoms, comorbidities, admission to intensive care units, and death rate by age groups will also provide a basis for understanding the disparity in death risk among age groups. The upper-age definition of adolescence has long posed a conundrum and varies across countries. Defining adolescence as age 10-24 years has been proposed to align more closely with adolescents' biological growth and social-role transitions, 2 and some studies on COVID-19 have included patients aged 0-24 years. 4 The study by Oliveira and colleagues 1 included patients younger than 20 years, and the inclusion of patients aged 21-24 years might provide a more comprehensive understanding of COVID-19 in adolescence. We declare no competing interests. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database The age of adolescence Global strategy for women's, children's and adolescents' health Sauber-Schatz EK. COVID-19 trends among persons aged 0-24 years: United States We thank Jonas Carneiro Cruz and col leagues and Siyu Chen and Yong Shao for their interest in our study in The Lancet Child & Adolescent Health. 1 Here, we further discuss some findings and methodological aspects, specifically the question of the effect of age and comorbidities in the prognosis of paediatric COVID-19.Cruz and colleagues raised concerns about grouping different clinical disorders in a single categorical variable. This issue is interesting from both clinical and methodological points of view. We tested various models that included the variable comorbidities, as dichotomous, categorical, or continuous, and also models including the main chronic pre-existing conditions as separate covariates. In this regard, we did not observe any superiority in clinical contribution among the different